/
/
/

Novartis India Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022Dec 2021Sep 2021Jun 2021Mar 2021Dec 2020Sep 2020Jun 2020Mar 2020Dec 2019Sep 2019Jun 2019Mar 2019Dec 2018Sep 2018Jun 2018Mar 2018Dec 2017Sep 2017Jun 2017Mar 2017Dec 2016Sep 2016Jun 2016Mar 2016Dec 2015Sep 2015Jun 2015Mar 2015Dec 2014Sep 2014Jun 2014Mar 2014Dec 2013Sep 2013Jun 2013Mar 2013Dec 2012Sep 2012
₹104 Cr₹91 Cr₹86 Cr₹90 Cr₹88 Cr₹84 Cr₹93 Cr₹87 Cr₹92 Cr₹81 Cr₹85 Cr₹79 Cr₹91 Cr₹76 Cr₹80 Cr₹102 Cr₹121 Cr₹98 Cr₹99 Cr₹104 Cr₹98 Cr₹99 Cr₹94 Cr₹96 Cr₹92 Cr₹94 Cr₹117 Cr₹118 Cr₹109 Cr₹110 Cr₹136 Cr₹107 Cr₹138 Cr₹125 Cr₹156 Cr₹168 Cr₹115 Cr₹145 Cr₹164 Cr₹175 Cr₹171 Cr₹166 Cr₹192 Cr₹224 Cr₹223 Cr₹208 Cr₹222 Cr₹235 Cr₹209 Cr₹201 Cr₹224 Cr₹214 Cr₹223 Cr₹213 Cr₹234 Cr₹237 Cr
₹9 Cr₹10 Cr₹9 Cr₹9 Cr₹11 Cr₹11 Cr₹11 Cr₹10 Cr₹10 Cr₹10 Cr₹22 Cr₹17 Cr₹12 Cr₹16 Cr₹8 Cr₹7 Cr₹27 Cr₹14 Cr₹6 Cr₹6 Cr₹6 Cr₹12 Cr₹8 Cr₹6 Cr₹7 Cr₹8 Cr₹7 Cr₹10 Cr₹11 Cr₹13 Cr₹11 Cr₹31 Cr₹22 Cr₹110 Cr₹14 Cr₹25 Cr₹23 Cr₹15 Cr₹15 Cr₹19 Cr₹21 Cr₹21 Cr₹82 Cr₹129 Cr₹20 Cr₹37 Cr₹23 Cr₹23 Cr₹25 Cr₹26 Cr₹23 Cr₹26 Cr₹21 Cr₹22 Cr₹20 Cr₹20 Cr
₹113 Cr₹101 Cr₹95 Cr₹100 Cr₹98 Cr₹95 Cr₹104 Cr₹97 Cr₹103 Cr₹92 Cr₹107 Cr₹96 Cr₹103 Cr₹93 Cr₹89 Cr₹108 Cr₹147 Cr₹113 Cr₹105 Cr₹111 Cr₹105 Cr₹112 Cr₹102 Cr₹101 Cr₹99 Cr₹102 Cr₹125 Cr₹128 Cr₹120 Cr₹124 Cr₹147 Cr₹138 Cr₹160 Cr₹235 Cr₹171 Cr₹193 Cr₹138 Cr₹160 Cr₹179 Cr₹194 Cr₹193 Cr₹187 Cr₹274 Cr₹353 Cr₹243 Cr₹244 Cr₹246 Cr₹257 Cr₹234 Cr₹226 Cr₹247 Cr₹239 Cr₹244 Cr₹235 Cr₹254 Cr₹258 Cr
₹69 Cr₹70 Cr₹64 Cr₹67 Cr₹61 Cr₹61 Cr₹68 Cr₹70 Cr₹69 Cr₹70 Cr₹65 Cr₹63 Cr₹75 Cr₹69 Cr₹74 Cr₹87 Cr₹90 Cr₹94 Cr₹95 Cr₹100 Cr₹93 Cr₹87 Cr₹100 Cr₹89 Cr₹91 Cr₹86 Cr₹112 Cr₹124 Cr₹118 Cr₹91 Cr₹123 Cr₹125 Cr₹142 Cr₹148 Cr₹145 Cr₹152 Cr₹128 Cr₹153 Cr₹158 Cr₹160 Cr₹163 Cr₹155 Cr₹195 Cr₹214 Cr₹223 Cr₹192 Cr₹241 Cr₹236 Cr₹213 Cr₹194 Cr₹225 Cr₹226 Cr₹221 Cr₹205 Cr₹212 Cr₹199 Cr
₹44 Cr₹31 Cr₹31 Cr₹33 Cr₹38 Cr₹35 Cr₹36 Cr₹28 Cr₹34 Cr₹22 Cr₹42 Cr₹34 Cr₹30 Cr₹26 Cr₹16 Cr₹23 Cr₹58 Cr₹20 Cr₹13 Cr₹13 Cr₹14 Cr₹28 Cr₹5 Cr₹16 Cr₹11 Cr₹19 Cr₹16 Cr₹7 Cr₹6 Cr₹33 Cr₹25 Cr₹14 Cr₹19 Cr₹88 Cr₹26 Cr₹41 Cr₹11 Cr₹9 Cr₹22 Cr₹35 Cr₹31 Cr₹34 Cr₹80 Cr₹141 Cr₹21 Cr₹54 Cr₹5 Cr₹22 Cr₹22 Cr₹33 Cr₹23 Cr₹15 Cr₹23 Cr₹31 Cr₹43 Cr₹59 Cr
₹6 L₹7 L₹98 L₹11 L₹10 L₹12 L₹36 L₹14 L₹15 L₹16 L₹16 L₹71 L₹46 L₹30 L₹46 L₹49 L₹50 L₹33 L₹1 Cr₹2 Cr₹2 Cr₹3 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹1 Cr₹0₹3 L₹3 L₹2 Cr₹5 Cr₹32 L₹5 L₹2 L₹39 L₹25 L₹4 L₹4 L₹4 L₹5 L₹6 L₹6 L₹5 L₹5 L₹6 L₹5 L₹6 L₹7 L₹6 L₹7 L₹0₹46 L₹4 L
₹43 Cr₹30 Cr₹30 Cr₹33 Cr₹37 Cr₹34 Cr₹35 Cr₹28 Cr₹34 Cr₹21 Cr₹41 Cr₹32 Cr₹28 Cr₹23 Cr₹14 Cr₹21 Cr₹57 Cr-₹31 Cr₹8 Cr₹9 Cr₹10 Cr₹22 Cr₹68 L₹11 Cr₹6 Cr₹14 Cr₹11 Cr₹2 Cr₹1 Cr₹32 Cr₹24 Cr₹13 Cr₹17 Cr₹82 Cr₹25 Cr₹40 Cr₹10 Cr₹7 Cr₹21 Cr₹34 Cr₹30 Cr₹33 Cr₹79 Cr₹140 Cr₹20 Cr₹53 Cr₹4 Cr₹21 Cr₹21 Cr₹32 Cr₹22 Cr₹14 Cr₹22 Cr₹30 Cr₹42 Cr₹58 Cr
₹32 Cr₹25 Cr₹16 Cr₹24 Cr₹28 Cr₹29 Cr₹25 Cr₹20 Cr₹26 Cr₹15 Cr₹27 Cr₹24 Cr₹20 Cr₹25 Cr₹8 Cr₹18 Cr₹52 Cr-₹23 Cr₹6 Cr₹7 Cr₹6 Cr₹10 Cr-₹71 L₹8 Cr₹4 Cr₹7 Cr₹8 Cr-₹5 Cr₹79 L₹20 Cr₹13 Cr₹9 Cr₹10 Cr₹26 Cr₹19 Cr₹26 Cr₹7 Cr₹3 Cr₹13 Cr₹22 Cr₹19 Cr₹23 Cr₹58 Cr₹104 Cr₹13 Cr₹52 Cr-₹1 Cr₹14 Cr₹14 Cr₹24 Cr₹15 Cr₹46 Cr₹14 Cr₹24 Cr₹29 Cr₹39 Cr

Share Price Live Stats

Open (₹)1,614.90
Volume (₹)17,952.00
High (₹)1,665.00
Upper Circuit1,936.90
Low (₹)1,614.90
Lower Circuit1,291.30
Prev Close1,614.10
52W High (₹)1,780.00
Price1,650.00
52W Low (₹)950.00

Share Market Cap & Key Ratios Overview

M.Cap (₹)3987.44 Cr
Div. Yield (%)0.00
PE Ratio40.78
Debt to Equity0.00
Price to Book2.47
Book Value318.06
EPS (TTM)39.60
Face Value5.00
ROE (%)13.19

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
ADANIENTNSE
PREMIERENENSE
AEGISLOGNSE
CPPLUSNSE
REDINGTONNSE
HONASANSE
LLOYDSENTNSE
SGMARTNSE
MMTCNSE
ENTERONSE
NOVARTINDNSE
LTP
1W Low
1W High
Market cap (₹)
2939.7-228.8 (-7.22%)
2830.50
3165
3,90,684Cr
1003.4-10.5 (-1.04%)
995.10
1036.30
45,486Cr
1272.4-17 (-1.32%)
1180
1327.30
45,144Cr
3650.9+74.3 (2.08%)
3460.20
3797.90
44,346Cr
370.1+4.1 (1.12%)
343.70
378.80
29,113Cr
470.7+0.05 (0.01%)
464.60
492.60
15,566Cr
73.9+0.37 (0.50%)
69.51
74.69
10,984Cr
817.2+27.9 (3.53%)
785.50
859.95
10,266Cr
64.25+1.18 (1.87%)
61.41
66.20
9,342Cr
1829.8+21.2 (1.17%)
1742.60
1868.90
8,041Cr
1650+163.7 (11.01%)
1480
1665
3,987Cr

Key Highlights of Novartis India Ltd’s P&L

In 2025-03-31, Novartis India Ltd reported total revenue of ₹356.27Cr, compared with ₹335.07Cr in 2024-03-31, reflecting Novartis India Ltd turnover.

Depreciation was ₹2.19Cr and finance costs were ₹77Lakh in 2025-03-31

Profit Before Tax (PBT) has been ₹130.42Cr in 2025-03-31 as compared to ₹122.84Cr in 2024-03-31.

Net Profit (PAT) was ₹100.9Cr in 2025-03-31 compared with ₹85.19Cr in 2024-03-31.

Earnings per share (EPS) were ₹40.88 in 2025-03-31, compared with ₹34.52 in 2024-03-31.